September 29, 2016 8:01 AM ET

Pharmaceuticals

Company Overview of Depomed, Inc.

Executive Profile

John Joseph DeLucca

Director Nominee, Depomed, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 13 different industries.

See Board Relationships
73--

Background

Mr. John Joseph DeLucca has been the President at Atlantic & Gulf Limited LLC since April 2004. Mr. DeLucca served as the Chief Financial Officer and Executive Vice President of REL Consultancy Group from April 2003 to March 2004. He served as the Chief Financial Officer and Executive Vice President of Finance & Administration of Coty Inc., from January 1999 to February 2002. While at Coty Inc., he was responsible for all global finance and administration operations, ...

Corporate Headquarters

7999 Gateway Boulevard
Newark, California 94560

United States

Phone: 510-744-8000
Fax: 510-744-8001

Board Members Memberships

Vice Chair of Board of Trustees
Director
2006-Present
Director, Chairman of Audit Committee and Member of Compensation Committee
2013-Present
Independent Director, Member of Audit Committee, Member of Nominating Committee and Member of Compensation Committee

Education

MBA
Fairleigh Dickinson University
BA
Bloomfield College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Cohen M.D.Founder, Chief Executive Officer, President and Director
Acorda Therapeutics, Inc.
$768.8K
Steven M. Klosk Chief Executive Officer, President and Director
Cambrex Corporation
$591.7K
William S. Marth Chief Executive Officer, President and Director
Albany Molecular Research Inc.
$650.0K
Arthur P. Bedrosian J.D.Chief Executive Officer, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
$1.4M
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director, Member of Pricing Committee and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.4M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Depomed, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.